+58%

est. 2Y upside i

DevOps & InfraSeries A

Autonomous coding agent right in your IDE, capable of creating/editing files, executing commands, using the browser, and more with your permission every step of the way.

Rank

#1445

Sector

Developer Tools

Est. Liquidity

~5Y

Data Quality

Data: Medium

Cline is a genuinely high-risk opportunity: the 22x ARR entry multiple ($110M on $5M ARR), a 29.1% preference stack from $32M in funding, and a confirmed February 2026 supply chain attack combine to produce a 50% bear-scenario probability where common equity could be wiped out entirely.

Last updated: May 14, 2026

Bull (20%)+380%

Cline recovers from its security incidents, becomes the default enterprise open-source AI coding agent, and scales to ~$35M ARR by 2028 — a 7x increase from the $5M baseline. At a 20x ARR multiple consistent with high-growth developer-tools comps, the company reaches a ~$700M valuation, implying roughly a 5.4x gross return on equity priced at the $110M Series A.

Base (30%)+60%

Cline grows steadily to ~$18M ARR by 2028 but faces meaningful share erosion from GitHub Copilot, Amazon Q, and Google Gemini Code Assist, compressing exit multiples to ~10x ARR. This supports a ~$180M valuation — roughly 1.6x the $110M entry — yielding modest positive gross returns before accounting for dilution from an expected Series B.

Bear (50%)-72%

The February 2026 OpenClaw supply chain attack causes sustained enterprise churn and reputational damage, stalling growth near $7M ARR as security-sensitive buyers at SAP, Samsung, and Fortune 100 accounts pause deployments. A distressed acquisition or down-round values the company at ~$30M, and after $32M in liquidation preferences absorb all proceeds, common stockholders recover approximately zero — representing a ~72% loss on entry valuation.

Est. time to liquidity~5.0 years

Preference Stack Risk

high

Funding Intensity

2910%

$32M in total funding sits ahead of common equity on a $110M valuation (29.1% preference ratio, near the severe threshold of 30%); any exit below ~$32M returns nothing to common, and exits below ~$80M return substantially less than face value after standard 1x non-participating liquidation preferences are satisfied.

Dilution Risk

high

At $5M ARR with 11 employees, Cline will almost certainly require a Series B and likely a Series C to reach exit scale, with each round expected to dilute existing common holders by an estimated 15–25%, compounding the discount on current grants.

Secondary Liquidity

none

No secondary market activity is evident for a Series A company with only $32M raised; employees should assume equity is fully illiquid for at least 4–6 years absent a strategic acquisition.

Other 6 roles

View all 6 open roles at Cline

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Cline's data — designed to show you've done your homework.

  • 1

    Following the February 2026 OpenClaw supply chain attack on Cline CLI 2.3.0, what specific architectural changes and third-party security audits have been completed, and what was the measured impact on enterprise customer retention and new pipeline conversion?

  • 2

    Cline's model passes AI inference costs through to customers without markup — what is the sustainable long-term pricing strategy for Cline Teams, and what ARR milestone and headcount plan supports a Series B raise and at what target valuation?

  • 3

    What is the full liquidation preference structure across the $32M in total funding — are there participating preferred provisions — and does the company have any plans for employee secondary liquidity programs or tender offers in the next 18–24 months?

Community

Valuation Sentiment

Our model estimates +58% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.